FOLFOXIRI and Bevacizumab in Patients With Early-Onset Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies
Eur. J. Cancer 2022 May 01;167(2022)23-31, C Antoniotti, MM Germani, D Rossini, S Lonardi, F Pietrantonio, D Santini, F Marmorino, G Allegrini, F Daniel, A Raimondi, B Borelli, A Zaniboni, V Conca, J Abraham, D Spetzler, E Maiello, A Boccaccino, A Passardi, M Giordano, E Tamburini, MW Korn, G Masi, C CremoliniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.